Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R – PR Newswire
First and only approved peginterferon in combination with ribavirin for previously untreated children with chronic hepatitis C addresses unmet medical need KENILWORTH, N.J., Dec. 12 /PRNewswire-FirstCall/ — Schering-Plough Corporation (NYSE: SGP read more